31%
Specialty pharma company reduced average pre-submission revision cycles from 2.4 to 1.1 by embedding a content attribute classification model into the MLR submission workflow.
DAM Networks approaches AI programs from the opposite direction. The business outcome comes first: a specific decision that needs to improve, a process that needs to move faster, a cost that needs to fall by a defined amount. That outcome definition drives every subsequent choice: what data is needed, what model architecture is appropriate, how success is measured in production, and what behavioral change is required from the people the AI is meant to support.
The failure patterns in enterprise AI are specific and recurring. Understanding them before a program starts is the difference between an investment that produces returns and one that produces a well-documented proof of concept.
Programs begin with "we want to build a machine learning model" rather than "we need to reduce credit adjudication time by 40 percent." When the objective is framed as a technology capability, success criteria become technical: accuracy is tracked, business impact is not.
The data assessment happens, if at all, after the architecture is designed and the build timeline is committed. Discovering coverage gaps or inconsistent labeling after the model is built means the program needs to be partially rebuilt.
A model that achieves 91 percent accuracy on a test set is not the same as a model that changes a business outcome. Precision and recall are not business metrics.
AI programs are built by technology and data science teams, with business stakeholders consulted at the start and reengaged at launch. The result is a model whose outputs are technically sound but practically disconnected from how decisions are actually made.
When an AI system changes how a team makes decisions, that change requires deliberate design. Training, workflow integration, feedback mechanisms, and manager-level reinforcement must be architected alongside the model, not after go-live.
A pilot that produces strong results in one business unit creates pressure to expand. If the data pipeline, governance model, and integration architecture were not designed with expansion in mind, each new use case requires a near-complete rebuild.
The right starting point runs from outcome definition to data readiness to model selection to implementation, then to the sequence that produces results.
Applied to content production, knowledge management, and structured communication workflows. DAM designs generative AI programs that account for quality control, regulatory, and brand governance requirements.
Generative AI solutions →AI agents operating within defined boundaries: triaging requests, routing decisions, executing multi-step workflows, escalating exceptions. The design challenge is defining those boundaries correctly: where the agent acts, where it recommends, where human judgment stays in the loop.
AI Agent development →Predicting demand, detecting anomalies, scoring propensity, identifying risk patterns. Business value is created when the prediction is connected to a decision the organization is willing to change based on what the model says.
Machine Learning solutions →AI programs are only as strong as the data infrastructure beneath them. Data quality, accessibility, and governance determine whether an AI program can be sustained and scaled beyond the initial use case.
Data Analytics →Every AI engagement begins with a structured use case definition session that includes business and commercial stakeholders, not just IT and data teams. The output is a precisely scoped problem statement: the decision or process being targeted, the current performance baseline, the target outcome with a defined measurement period, and the threshold the model must reach to be commercially viable.
Before any model selection or architecture decision, DAM conducts a structured assessment of the data environment. This covers data availability, coverage across the target use case, quality and consistency of historical records, labeling integrity for supervised learning programs, and the integration complexity involved in making that data accessible to the model in production.
AI programs at DAM are structured around outcome milestones, not model deployment milestones. Each phase ends with a performance review against the outcome definition from Step 1, not a technical delivery checklist. Production AI systems also require the delivery infrastructure to sustain them: model serving pipelines, monitoring for prediction drift, and a governed process for how model versions move through validation into production.
The behavioral change layer is where most AI programs fail in production. DAM designs the adoption layer as a parallel workstream from the start of the engagement, covering interface design, workflow integration, training, manager enablement, and the feedback loops that allow the model to improve over time in live use. If the model outputs are not integrated into the workflows where decisions are made, adoption plateaus.
Specialty pharma company reduced average pre-submission revision cycles from 2.4 to 1.1 by embedding a content attribute classification model into the MLR submission workflow.
Manufacturer reduced production defects by building a predictive quality model on sensor data from five upstream production stages, with rework costs declining proportionately.
Financial services organization improved fraud detection precision and reduced false positive reviews by 34% by introducing a risk tiering layer that concentrated manual review on highest-confidence cases.
Residential developer segmented inbound inquiries into three priority tiers using a lead scoring model, reallocating sales capacity toward the highest-scoring tier with no increase in team size.
Foundation models are appropriate when the task is primarily generative and when the organization's proprietary data does not represent a structural advantage in the task being performed. Custom model development makes sense when the prediction problem is specific to the organization's data, when the performance requirements exceed what a general model can achieve on the specific task, or when regulatory or data privacy requirements prevent the use of external model providers. In most enterprise programs, the answer is a combination: foundation models for generative and language tasks, custom or fine-tuned models for prediction and operational intelligence applications where proprietary data and domain specificity determine model quality.
The data requirement depends entirely on the use case. What organizations consistently underestimate is not the volume of data required but the quality. Data that has been collected for reporting purposes often lacks the structure, consistency, and labeling required for model training. A data readiness assessment before the program begins identifies these gaps and scopes the work required to close them.
A focused, well-scoped AI use case with data that has been assessed as ready can move from scoping to initial production deployment in twelve to twenty weeks. Programs that skip the data readiness phase and discover gaps during build consistently take longer and cost more than programs that front-loaded that work.
Pharmaceutical AI programs at DAM are designed with regulatory requirements as a primary design constraint, not a secondary consideration. For programs that touch HCP data, adverse event data, or promotional content, the relevant regulatory frameworks are incorporated into the data handling and output review architecture. The compliance team is a stakeholder in the program design, not a reviewer brought in at the end.
AI governance is not a policy document. It is a set of operational controls embedded in how AI programs are built, monitored, and managed: a defined model inventory, a monitoring framework that detects model drift, explainability requirements matched to the decision context, a human-in-the-loop design for high-stakes decisions, and a process for handling model errors. Governance is designed into the program from the start.
The return on an AI program should be measured against the business metric it was designed to move, not against the model's technical performance. This requires that the business metric and the measurement methodology are agreed before the program begins, that the measurement baseline is established before deployment so the counterfactual is clear, and that the business outcome is tracked in production rather than only during pilot.
The organizations that see AI produce returns share a common starting point. They enter the program with a specific, measurable business problem, not a technology ambition. They are willing to do the data readiness work before the build work. And they treat the adoption of AI outputs as a design problem, not a training problem.